Pancreatic cancer has long carried poor prognosis. The development of new therapeutic approaches is particularly urgent. Inactivation of the tumor -suppressor gene p16
P
ancreatic cancer is one of the most aggressive human tumors and the fourth leading cause of cancer death in Europe and North America. 1 Nowadays, surgery is the only curative therapy. Despite the improvements in diagnosis and surgical treatment, most patients are not candidates for surgery and less than 5% of patients survives for 5 years. 2, 3 The development of new therapeutic approaches is therefore particularly urgent for pancreatic tumors.
One of the most promising approaches to emerge from the improved understanding of cancer at the molecular level is the possibility of using gene therapy to selectively target and destroy tumor cells. 4 -6 It has become clear that tumorigenesis is driven by alterations in genes that control cell growth or cell death. 7, 8 Despite the multiplicity of these lesions within a cancer cell, the correction of a single critical genetic lesion may be sufficient to abrogate tumorigenicity if the function restored succeeds in the reestablishment of growth control. 9 Research in cell cycle regulation has revealed a striking new regulatory network involving various tumor-suppressor genes and oncogenes. This network tightly regulates entry into the cell cycle in normal cells and it is probably deregulated in every tumor. 10 Functional inactivation of the p53 /MDM2 /p14 ARF and pRb /p16 /CDK4 /cycD pathways appears to be a fundamental requirement for the genesis of most human cancers because it results in disruption of cell cycle regulation and deactivation of the apoptotic response. 11, 12 The pRb protein inhibits genes required for S -phase entry and stimulates genes that are active in resting cells. 13 The function of pRb is regulated by phosphorylation, which is carried out by cyclin-dependent kinases CDK4 /6 and CDK2, sequentially acting in the G 1 phase. 10, 13, 14 The activity of these kinases is positively regulated by D -type or E -type cyclins, respectively, and can be downmodulated by kinase inhibitors (CKIs ). 15, 16 Changes in the activity of the pRb protein are accompanied by variations in the expression level and the state of phosphorylation of the other components of the retinoblastoma family, p107 and p130. 17 Complex interrelations between these pocket proteins and the regulation of transcription factors belonging to the E2F family may determine the final destination of a cycling cell. 16 -18 Among the different CKIs, the most altered in tumorigenesis is p16. 19, 20 The p16 gene ( INK4a, CDKN2, MTS ) localized to the 9p21 chromosomal region encodes for a CDK4/ 6-cyclin D complex inhibitor. 21 By preventing the formation of cyc / CDK complexes, the p16 protein inhibits the phosphorylation of pRb, which remains bound to E2F transcription factor, causing an arrest in the G 1 phase of the cell cycle. 22 It has been demonstrated that p16 level increases gradually as cells proceed toward senescence, and when expressed ectopically in mouse fibroblasts, it can elicit senescence. 23, 24 Moreover, p16 is probably the most important mediator of the induction of senescence in response to Ras activation, and this action probably constitutes the basis of its role as a tumor-suppressor gene in many cancers.
functions for p16. Apart from cell cycle control and senescence, 27 -31 p16 has been implicated in other fundamental cellular processes, such as angiogenesis, 32 tumor invasion, 33 cell spreading, 34, 35 and apoptosis. 36 -39 Taking into account the importance of p16 as a tumor suppressor, and its high frequency of alterations in pancreatic tumors, 20 we planned a strategy based on adenovirusmediated transduction of the p16 gene into a panel of human pancreatic tumor cells. Our results indicate that restoration of the p16 function caused significant inhibition of cell proliferation in all cell lines assayed and, depending on the genetic background of tumor cells, it even induces cell death. Moreover, experiments on human pancreatic tumors developed in the subcutaneous tissue of Balb /c mice have demonstrated that the reintroduction of wt -p16 gene also reduces tumor growth in vivo.
MATERIALS AND METHODS

Cell lines
NP -9, NP -18, NP -29, and NP -31 cell lines were derived from human pancreatic adenocarcinomas, which had been perpetuated as xenografts in nude mice. 40 NP -9 and NP -29 were grown in DMEM:F12 medium (1:1 ) and NP -18 and NP -31 in RPMI 1640 medium, both supplemented with 10% fetal bovine serum (FBS ) and antibiotics, in a humidified atmosphere containing 5% CO 2 at 378C. The status of p16, p53, and p21 genes and their expression levels in these cell lines are summarized in Table 1 .
Adenovirus and infection conditions
Replicative -deficient recombinant type 5 adenoviruses were used as vectors containing the complete p16 cDNA under a Rous Sarcoma Virus promotor (Ad5RSV-p16, Ad-p16 ), or the cDNA of -galactosidase under the Cytomegalovirus promotor (Ad5CMV-lacZ, Ad-lacZ ), or without insert ( Ad -control ). All viruses were cloned and amplified using the 293 cell line. Titration was done by plaque assay. Optimal infection conditions had been previously determined by transfection with Ad -lacZ and X -gal staining. 41 Cells were plated 24 hours before infection with Ad -p16 or Ad -control. The viral stock was diluted to reach a multiplicity of infection (MOI) of 50, added to cell monolayer, and incubated for 2 hours in serum -free medium at 378C. Infection was stopped by adding medium supplemented with 10% heat -shock inactivated FBS ( 30 minutes at 568C ). Mock -infected cells were incubated with serum -free medium.
Immunofluorescence assay
Cells were seeded on 10-mm coverslides in 60 -mm dishes (5 -10 coverslides per dish ). Infected cell monolayers were fixed 48 hours after infection with paraformaldehyde 4% in phosphate buffered saline (PBS ); after washing in PBS, cells were permeabilized by incubation for 10 minutes in 0.2% Triton X -100 in PBS. Immunodetection was performed after blocking with PBS -BSA 3% using a mouse antihuman monoclonal p16 antibody ( G175 -405; Pharmingen, San Diego, CA ) as primary antibody. Mouse IgG was used as control. The secondary antibody was an Alexa 488-conjugated goat antimouse ( Molecular Probes Europe, Leiden, the Netherlands ). All the antibodies were diluted in washing solution containing 0.5% BSA and 0.05% Tween -20 in PBS. Immunofluore ( ICN, Costa Mesa, CA ) was used as mounting medium. Photomicrographs were obtained in a Leica DMRB FLUO Microscope.
Western blotting analysis
Total cell lysates were obtained by incubating cells in RIPA buffer (150 mM NaCl, 1% sodium deoxycholate, 0.1% SDS, 20 mM EDTA, 1% Igepal CA -630, and 50 mM Tris, pH 7.4 ) for 1 hour at 48C and sonicating at 50 W for three cycles of 30 seconds. After centrifugation at 14,000 rpm, supernatant proteins ( 40 g /lane determined by BCA protein assay; Pierce Chemicals, Rockfield, IL) were subjected to electrophoresis on 8-12% SDS -PAGE and transferred to a nitrocellulose membrane ( Schleicher and Schuell, Dassel, Germany ). Membranes were blocked with Blotto-Tween ( 3% BSA, 0.05% Tween 20, 0.9% NaCl, and 50 mM Tris, pH 7.4 ) and incubated with the primary antibodies: mouse antihuman p16 ( G175 -405; Pharmingen ), mouse antihuman E2F -1 ( KH95; Santa Cruz Biotechnology, Santa Cruz, CA ) and mouse antihuman PARP (7D3 -6; Pharmingen ) monoclonal antibodies, goat antihuman pRb ( C -15; Santa Cruz ), and rabbit antihuman p107 (C -18; Santa Cruz) polyclonal antibodies, and with the secondary antibodies: HRPconjugated antimouse IgG ( DAKO, Carpinteria, CA ), HRP -conjugated antigoat IgG ( Santa Cruz), and HRPconjugated antirabbit IgG (Sigma Chemicals, St. Louis, MO ). Membranes were developed according to Amersham's ECL protocol ( Amersham, Arlington Heights, IL ). 
Cell growth curves
Cells were seeded at 10,000 cell /well in 24-well culture plates. Cells were infected with Ad -p16 or Ad -control at MOI of 50. Serum -free culture medium was used for mock infection. Quadruplicate wells of each treatment were counted periodically until the eighth day after infection in an auto -analyzer Multisizer ( Coulter, Hialeah, FL ).
Cell cycle analysis
All measurements of cell cycle distribution were performed on an EPICS -XL flow cytometer (Coulter ) equipped with an air-cooled argon ion laser to give 488 nm light.
Triplicates of cell cultures were harvested at different times after viral infections and stained in TBS containing propidium iodide (PI; 50 g/ mL ), ribonuclease A ( 10 g/ mL ), and Igepal CA -630 (0.1% ) for 1 hour at 48C. Data from at least 10,000 cells were collected and analysed by Multicycle software (Phoenix Flow Systems, San Diego, CA ).
-BrdU assay
To measure DNA synthesis, cells were incubated for 4 hours with 5-BrdU -containing medium (30 M). After the incubation, medium was aspirated and cells, at a concentration of 10 6 cells /mL, were fixed on ice -cold 70% ethanol. Fixed cells were pelleted, and DNA denaturation was performed by incubation in 0.1 M HCl, 0.5% Triton X -100 for 30 minutes at room temperature followed by 10 minutes at 908C. After blocking with FBS, 5 -BrdU incorporated into the DNA was immunodetected using an FITC -conjugated anti -5 -BrdU (Caltag Laboratories, Burlingame, CA ) and DNA was stained with 20 g /mL PI and 10 g/mL ribonuclease A in PBS. Analysis was performed on an EPICS -XL flow cytometer (Coulter ).
Apoptosis assays
Apoptosis was assessed by Annexin V-FITC binding ( Genzyme, Cambridge, MA ). Supernatant and plated cells were collected 48 and 72 hours after infection, washed in PBS, and resuspended in binding buffer. A total of 1Â10 6 cells were collected, washed in PBS, and resuspended in 1 mL binding buffer containing a final concentration of 0.5 g /mL Annexin V-FITC and 5 g/ mL PI. Cells were incubated at room temperature for 1 hour in the dark. Triplicate dishes of each sample were analysed with an EPICS -XL flow cytometer (Coulter ). PI -positive cells were considered as the necrotic population, and only PInegative, Annexin V-FITC -positive cells were considered as the apoptotic population.
Apoptosis was also assessed by Hoechst 33342 pulse labeling protocol, as described by Darzynkiewicz et al. 42 Chromatin condensed cells incorporate this dye more rapidly than viable or necrotic cells. Infected cells were 
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Cancer Gene Therapy, Vol 8, No 10, 2001 collected at days 1, 2, 3, and 4 after transfection, washed in PBS, counted, and resuspended at 10 6 cells/ mL in Hoechst 33342 containing PBS. After a 30 -second incubation, cells were analysed in an Epics Elite FACS ( Coulter ) equipped with a UV laser lamp. Stained cells were also observed and photomicrographed with an Olympus BH -2 Microscope.
Senescence -associated -gal staining
Six days after infection, cell monolayer was washed in PBS and fixed for 30 minutes in 4% paraformaldehyde in PBS. The method for senescence -associated -galactosidase (SA--gal ) staining was performed as described by Dimri et al. 43 Photomicrographs were obtained in an Olympus IMT-2 Inverted Microscope.
Experiments in vivo
Animal care and use were in accordance with recommendations for the Proper Care and Use of Laboratory Animals. A total of 2Â10 7 NP -9 or NP -18 tumor pancreatic cells were injected subcutaneously ( s.c. ) into each posterior flank region of BALB /c nude mice. Tumors were allowed to grow for 16 days and experiments were started with tumors of 46± 9 mm 3 for NP -9 and 103± 49 mm 3 for NP -18. The tumors were divided into four groups: groups 1 (NP -9 control ) and 
Statistical analysis
The Mann -Whitney nonparametric test was used on paired data, and significance was set at P < .05. Immunohistochemistry of tumor sections Some of the tumors were treated a fourth time on day 21 in order to obtain tumoral tissue samples. Three days after the last injection, mice were sacrificed and tumors were excised, fixed in formalin, embedded in paraffin, and stored for further experiments. Five micrometer paraffin sections was mounted on coated glass slides, baked for 20 minutes at 608C, and dewaxed. Immunodetection of p16 was performed after heat antigen retrieval using a mouse antihuman monoclonal p16 antibody ( G175 -405; Pharmingen ) as primary antibody. Mouse IgG was used as control. The secondary antibody was an ENVISION antimouse (DAKO ). Slides were developed with DAB and counterstained with hematoxylin.
RESULTS
Infection conditions and p16 expression
The four human adenocarcinoma pancreatic cell lines (NP -9, NP -18, NP -29, and NP -31 ) were efficiently transduced with the Ad -p16 vector. Cells were infected with Ad -p16 at variable MOI to identify a dose that would produce detectable p16 expression and a clear functionality of the expressed protein without cytotoxic effects in cells transduced with Ad -control (data not shown). For most experiments, the virus concentration was fixed at 50 MOI. The expression of exogenous p16 was analyzed by Western blot ( Fig 1A ) . Exogenous p16 was detected in all four cell lines 24 hours after the infection and reached its maximum at 48-96 hours, decreasing progressively thereafter. In all cell lines, p16 expression was at least 50% of the maximum on the eighth day after infection (data not shown ). Subcellular localization was assessed by immunocytochemistry on the third day after infection. Fluorescence observed in Ad -p16-infected cells indicates that the exogenous protein localized both in the nucleus and in the cytoplasm ( Fig 1B ) .
Cell growth and morphology after infection with Ad -p16
Cell growth curves of the four cell lines showed a significant growth inhibition after the second day postinfection (Fig  2A ) . The inhibitions ranged from 30% in NP -29 cells to 85% in NP -18 cultures. The progressive slowing of cell proliferation was accompanied by morphological changes in the transduced tumor cells (Fig 2B ) . In three of the four cell lines assayed, cells acquired a more refractile cytoplasm and showed a flattened and enlarged morphology, characteristic of arrested or senescent cells. In contrast, a significant proportion of NP -18 cells showed typical features of apoptotic status; cells shrank, separated from their neighbors, appeared refringent, and finally detached from the monolayer by day 3 after infection.
Cell cycle and senescence analysis
In order to determine the mechanism of growth inhibition elicited by p16 overexpression in our pancreatic cell lines, the cell cycle was analyzed at different times after viral infection. In NP -9 cells, the expression of exogenous p16 led to a marked G 1 arrest. The ratio G 1 /S in transduced NP -9 cells varied from an initial value of 2.5 to 16.9 after infection. In contrast, NP -18 cells did not show cell cycle arrest in G 1 phase after Ad -p16 infection, whereas a significant population was observed to be in sub -G 1 phase, suggesting that the exogenous p16 expression causes apoptosis in these cells (Fig 3A ) . To corroborate the a b c d
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Ad-control Ad-p16 (Table 2 ) . We also determined the presence of senescence features in p16 -transduced cells. Acidic X -gal staining indicated that NP -9, NP -29, and NP -31 cells were committed to a senescent phenotype, as assessed by the increase in their SA --gal activity. NP -18 cells did not show any increase in SA --gal activity, corroborating the different destination of these cells when p16 is overexpressed ( Fig 4 ) .
Apoptosis determination
We determined the percentage of apoptotic cells in cell lines infected with Ad -p16 by two methods: Annexin V and Hoechst 33342 pulse labeling. Both analyses showed that p16 overexpression increased the apoptosis level only in NP -18 cells (Fig 5A ) . In NP -9, NP -29, and NP -31 cell lines, no significant increases in apoptosis were found ( Fig  5A, Table 2 ).
To check the apoptosis observed in p16-transduced NP -18 cells by other methods, cell extracts were prepared at different times postinfection (days 1, 2, 3, and 4) and examined for evidence of poly( ADP -ribose ) polymerase ( PARP ) cleavage. In the Western blot shown in Figure 5B , the 85-kDa cleavage product was only observed in extracts from NP -18 cells infected with Ad -p16, confirming that these cells underwent apoptosis when p16 was overexpressed.
Apoptosis induced in NP -18 cells was also visualized by incubation with the vital DNA dye Hoechst 33342. Transduced NP -18 cells showed characteristic morphological patterns with condensed chromatin in the nucleus and the appearance of apoptotic bodies, whereas in control cells, these features were not seen ( Fig 5C ) .
Effect of the reintroduction of wt -p16 on pRb, p107, and E2F -1 expression
Western blot analysis performed with NP -9 and NP -18 cell extracts at different times postinfection with Ad -p16 showed that, concomitant to high levels of p16 expression, the pRb protein exhibited hypophosphorylation (Fig 6 ) . In addition, a marked decrease in the level of total pRb was observed by day 3 postinfection. Similar results were obtained with NP -29 and NP -31 cell lines (data not shown). To check differences in the expression levels of other proteins involved in the cell cycle arrest, we performed Western blots of the same cell extracts using antibodies against p107 and E2F -1. For both proteins, we observed a dramatic decrease in expression in NP -9 cell extracts, whereas no significant variations were observed in NP -18 cell extracts ( Fig 6) .
Experiments in vivo
We have previously determined the efficiency of adenoviral transduction in vivo by using a vector containing a marker gene, Ad -lacZ. -gal -expressing areas were evaluated after intratumoral injection of 2.4Â10 8 pfu of this vector. At 2 days after virus administration, X -gal staining showed that the expression of -galactosidase was restricted to patches of -gal -expressing cells around the injection points in the tumors. 44 No more than 20% of reduction in tumor growth was observed in animals treated with Ad -lacZ at the same dose as for Ad -p16 (data not shown ).
Here, we examined the capacity of Ad -p16 to inhibit the growth of tumors in vivo. Human tumors were developed in the s.c. tissue of nude mice and treated as described in Materials and Methods. Marked reductions in tumor volumes were observed in the Ad -p16 -treated groups corresponding to both NP -18 and NP -9 when compared with the control groups. Statistically significant differences were found from day 10 after the start of treatment in NP -18 tumors, and from day 21 in NP -9 tumors. In spite of the market inhibition of the growth observed in NP -18 tumors, no absolute decreases in volume were observed. NP -9 tumors treated with Ad -p16 showed greater inhibition of growth than NP -18 tumors. Moreover, NP -9 tumors showed a pronounced reduction in the size after the third administration of Ad -p16. This decrease was observed for 15 days ( Fig 7A ) .
Immunohistochemistry of p16 on tumor sections revealed exogenous p16 expression in localized groups of cells, confirming the difficulty of delivering the therapeutic gene to the whole tumor ( Fig 7B ) . To determine the impact of p16 on the proliferation index of tumors, we performed Ki67 immunodetection. NP -18 tumors had a much bigger proliferation rate than NP -9 tumors because they presented 60 -80% vs 2-5% Ki67 -positive cells, respectively, but no relevant differences between groups of treatment were found ( data not shown ).
DISCUSSION
The availability of new human pancreatic cell lines with marked differences in the status of several genes involved in the control of the cell cycle and apoptosis, such as p16 and p53 ( Table 1 ) , makes it possible to study the impact of p16 overexpression in different models of human pancreatic cancer both in vitro and in vivo.
Adenoviruses are excellent tools to transfer genes to human tumors owing to their efficiency in infecting human cells and their low toxicity in vitro and in vivo. 45 However, several problems still stand in the way of optimal results, such as their immunogenicity, which limits virus dissemination. 46 Another limitation for their use in therapy is the lack of specificity, which may be overcome by using targeted vectors and /or regional perfusion. 47, 48 Nevertheless, until more potent and specific vectors (ideal vectors) are developed, preclinical assays are needed to identify the most suitable genes for therapeutic approaches. In the present study, we have addressed this last point. As a very high percentage of pancreatic tumors have lost p16 expression, 20 it is predictable that reintroduction of functional p16 gene could be an effective molecular approach to the treatment of these tumors.
When wt-p16 gene was delivered to our pancreatic cell lines by using Ad5RSV-p16, Western blot analysis demonstrated that expression of the p16 protein was significantly increased in all infected cells and maintained long enough to achieve notable effects on cell proliferation. Immunocytochemical analysis performed on the third day after infection revealed that the newly expressed p16 was located both in the nucleus and in the cytoplasm of all transduced cell lines. This result could be consistent with the additional roles attributed to p16 other than control of cell cycle, which are fulfilled in cell cytoplasm, such as cell membrane -associated activities during cell proliferation and migration. 33 -35 In all cell lines, the newly expressed p16 was functional. Inhibition of cell growth was observed in all treated cells, and was significant from day 2 after infection. In three of four cell lines assayed, this inhibition was associated with G 1 arrest and subsequent acquisition of the senescence phenotype. This behavior, observed in all p16 -negative cells, is in agreement with previous results of Ad5RSV-p16 -treated cells 28, 29, 31 and plasmid -p16 transfection experiments. 49 The only cell line that contains endogenous wt-p16 did not exhibit G 1 arrest and senescence phenotype. This difference in behavior strongly suggests that these cells have the ability to overcome the cell cycle arrest imposed by p16, probably because of an additional alteration in the same pathway. This is consistent with the current hypothesis that whole pathways should be considered, rather than alterations to specific genes. In this respect, there is substantial evidence in favor of alterations in different components of the main pathways involved in tumorigenesis ( p53 and p16/pRb pathways ), which allow transformation of the cell by an oncogenic stimulus. 11, 50 Interestingly, NP -18 cells suffered the greatest growth inhibition when p16 was overexpressed, and the results demonstrated that this inhibition was due to the induction of apoptosis. In the last years, emerging evidence has been reported showing that apoptosis may be induced by p16 overexpression, particularly if p53 is also overexpressed, but no clear explanation for the mechanisms of such apoptosis has been provided until now. 36 -39,51,52 One hypothesis that relates the inhibition of CDK4 /CycD complexes with apoptosis is that it arises from a decrease in the pRb levels observed when p16 blocks this pathway. 53 Low pRb levels may be enough to cancel the protective effect of pRb, releasing the E2F -1 factor, which in turn would induce apoptosis by p53 -dependent or p53 -independent pathways. 54, 55 Indeed, the results obtained with the different cell lines may support this hypothesis. While all four cell lines showed a reduction of pRb levels over time, important differences in the levels of p107 and E2F -1 were observed between NP -9 and NP -18 cell lines. In NP -9 cells, p107 and E2F -1 disappeared concomitantly to the reductions in pRb levels, whereas in NP -18 cells, this disappearance was not observed. These differences might determine whether cells enter the normal program of cell cycle arrest and subsequent senescence or are committed to other final destinations. However, we cannot rule out that p16 may induce apoptosis by other very recently described mechanisms, such as a regulation of cell -cell and /or cellextracellular matrix interactions. 56 In vivo experiments are also informative because the results indicate that p16 overexpression is also able to elicit an important inhibition of tumor growth. In spite of the low extent of tumor areas transduced, the differences in tumor growth are statistically significant from day 10 in NP -18 model and from day 21 in NP -9 tumors ( P <.05). Surprisingly, the impact on tumor growth achieved in Adp16 -treated NP -18 tumors was lower than that reached in NP -9 tumors. These differences may be related to the slower growth of NP -9 tumors, correlating with the doubling times calculated in vitro. The marked reductions in tumor growth observed in both models suggest that both cell cycle arrest and apoptosis induction may generate an important response in vivo. However, the sustained volume decrease observed in NP -9 tumors over 15 days indicates the possibility of inducing cell death in NP -9 cells in vivo, in contrast to that observed in vitro. A change in the response of tumor cells to suppressor genes reintroduction in three -dimensional growth with respect to that observed in monolayer cultures has been also described in other models. 9, 32, 57 This change must be related to the implication of p16 in anchorage dependence, tumor invasion, and angiogenesis and confers an additional value to p16 reconstitution as therapeutic modality. 32 -35 Considered as a whole, our results indicate that the effects of p16 overexpression may depend on the state of the genes involved in the cell cycle machinery and/ or apoptotic pathways. Interestingly, irrespective of the nature of the effect produced, p16 leads to a significant decrease in tumor cell growth in vitro and in vivo, even if functional p16 is already present in the cell. This constitutes a very promising feature that suggests that the introduction of wtp16 may be a key component of therapies aiming to enhance the natural mechanisms of cell proliferation control.
